These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 23612355
1. Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers. Zhao C, Fan T, Yang Y, Wu M, Li L, Zhou Z, Jian Y, Zhang Q, Huang Y. Int J Pharm; 2013 Jun 25; 450(1-2):11-20. PubMed ID: 23612355 [Abstract] [Full Text] [Related]
2. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Xu X, Zhao C, Yang H, Jian Y, Zhang Z, Huang Y. Drug Deliv; 2011 Jun 25; 18(7):485-92. PubMed ID: 21692681 [Abstract] [Full Text] [Related]
3. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Beloqui A, Coco R, Alhouayek M, Solinís MÁ, Rodríguez-Gascón A, Muccioli GG, Préat V. Int J Pharm; 2013 Oct 01; 454(2):775-83. PubMed ID: 23694806 [Abstract] [Full Text] [Related]
4. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration. Zhao C, Liu Y, Fan T, Zhou D, Yang Y, Jin Y, Zhang Z, Huang Y. Pharm Dev Technol; 2012 Oct 01; 17(4):443-56. PubMed ID: 21222507 [Abstract] [Full Text] [Related]
5. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K. Int J Nanomedicine; 2019 Oct 01; 14():6135-6150. PubMed ID: 31447556 [Abstract] [Full Text] [Related]
6. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z. Int J Pharm; 2012 Jul 01; 430(1-2):292-8. PubMed ID: 22486962 [Abstract] [Full Text] [Related]
8. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J, Pathak A, Kishore R, Chauhan MK. Drug Dev Ind Pharm; 2013 Apr 01; 39(4):569-78. PubMed ID: 22639934 [Abstract] [Full Text] [Related]
10. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY. Nanotechnology; 2010 Oct 08; 21(40):405101. PubMed ID: 20823498 [Abstract] [Full Text] [Related]
16. In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system. Wang MT, Jin Y, Yang YX, Zhao CY, Yang HY, Xu XF, Qin X, Wang ZD, Zhang ZR, Jian YL, Huang Y. Int J Nanomedicine; 2010 Aug 09; 5():487-97. PubMed ID: 20957171 [Abstract] [Full Text] [Related]
17. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Zhang T, Chen J, Zhang Y, Shen Q, Pan W. Eur J Pharm Sci; 2011 Jun 14; 43(3):174-9. PubMed ID: 21530654 [Abstract] [Full Text] [Related]